Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lichun Wei

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
BMC Cancer|March 15, 2022
Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in ChinaWenhui Wang, Tiejun Wang, Zi Liu, et al.
BMC Women'S Health|August 8, 2023
Practice patterns of adjuvant radiotherapy in women with stage I to II endometrial carcinoma: a real-world multi-institutional analysis in ChinaWenhui Wang, Tiejun Wang, Zi Liu, et al.
Asia-Pacific Journal of Clinical Oncology|November 10, 2022
Preoperative serum CA125 level and age at diagnosis: An effective prognosis prediction tool for patients with early-stage endometrial cancerShuai Sun, Lichun Wei, Lijuan Zou, et al.
Cancers|October 27, 2022
Utilization Trend and Comparison of Different Radiotherapy Modes for Patients with Early-Stage High-Intermediate-Risk Endometrial Cancer: A Real-World, Multi-Institutional StudyKang Ren, Lijuan Zou, Tiejun Wang, et al.
Aging|August 9, 2021
Effect of age as a continuous variable in early-stage endometrial carcinoma: a multi-institutional analysis in ChinaShuai Sun, Lijuan Zou, Tiejun Wang, et al.
BMC Cancer|July 4, 2021
Treatment optimization of pelvic external beam radiation and/or vaginal brachytherapy for patients with stage I to II high-risk Endometrioid adenocarcinoma: a retrospective multi-institutional analysisWenhui Wang, Lijuan Zou, Tiejun Wang, et al.
Eclinicalmedicine|July 17, 2025
Total neoadjuvant therapy integrating long-course radiotherapy with trifluridine/tipiracil for locally advanced rectal cancer: a single-arm, multicenter phase 2 trialXue Dou, Lina Zhao, Zhenyu Ma, et al.
Frontiers in Oncology|August 15, 2020
Comparison of Hematologic Toxicity and Bone Marrow Compensatory Response in Head and Neck vs. Cervical Cancer Patients Undergoing ChemoradiotherapyLucas K Vitzthum, Elena S Heide, Helen Park, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|July 18, 2024
Preoperative short-course radiotherapy followed by chemotherapy and PD-1 inhibitor administration for locally advanced rectal cancer: A study protocol of a randomized phase II/III trial (STELLAR II study)Wenjue Zhang, Yuan Tang, Lichun Wei, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2025
Nimotuzumab plus image-guided radiotherapy for elderly patients with locally advanced cervical squamous cell carcinoma: Interim analysis of a prospective multi-center phase Ⅱ trialAng Qu, Yanhong Zhuo, Hong Zhu, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
BMC Cancer|March 15, 2022
Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in ChinaWenhui Wang, Tiejun Wang, Zi Liu, et al.
BMC Women'S Health|August 8, 2023
Practice patterns of adjuvant radiotherapy in women with stage I to II endometrial carcinoma: a real-world multi-institutional analysis in ChinaWenhui Wang, Tiejun Wang, Zi Liu, et al.
Asia-Pacific Journal of Clinical Oncology|November 10, 2022
Preoperative serum CA125 level and age at diagnosis: An effective prognosis prediction tool for patients with early-stage endometrial cancerShuai Sun, Lichun Wei, Lijuan Zou, et al.
Cancers|October 27, 2022
Utilization Trend and Comparison of Different Radiotherapy Modes for Patients with Early-Stage High-Intermediate-Risk Endometrial Cancer: A Real-World, Multi-Institutional StudyKang Ren, Lijuan Zou, Tiejun Wang, et al.
Aging|August 9, 2021
Effect of age as a continuous variable in early-stage endometrial carcinoma: a multi-institutional analysis in ChinaShuai Sun, Lijuan Zou, Tiejun Wang, et al.
BMC Cancer|July 4, 2021
Treatment optimization of pelvic external beam radiation and/or vaginal brachytherapy for patients with stage I to II high-risk Endometrioid adenocarcinoma: a retrospective multi-institutional analysisWenhui Wang, Lijuan Zou, Tiejun Wang, et al.
Eclinicalmedicine|July 17, 2025
Total neoadjuvant therapy integrating long-course radiotherapy with trifluridine/tipiracil for locally advanced rectal cancer: a single-arm, multicenter phase 2 trialXue Dou, Lina Zhao, Zhenyu Ma, et al.
Frontiers in Oncology|August 15, 2020
Comparison of Hematologic Toxicity and Bone Marrow Compensatory Response in Head and Neck vs. Cervical Cancer Patients Undergoing ChemoradiotherapyLucas K Vitzthum, Elena S Heide, Helen Park, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|July 18, 2024
Preoperative short-course radiotherapy followed by chemotherapy and PD-1 inhibitor administration for locally advanced rectal cancer: A study protocol of a randomized phase II/III trial (STELLAR II study)Wenjue Zhang, Yuan Tang, Lichun Wei, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2025
Nimotuzumab plus image-guided radiotherapy for elderly patients with locally advanced cervical squamous cell carcinoma: Interim analysis of a prospective multi-center phase Ⅱ trialAng Qu, Yanhong Zhuo, Hong Zhu, et al.
Pageof 6